In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian FDA takes first step in possible reversal of ban on some peptides The Washington Post What Are Injectable Peptides? Here's Why Doctors Are Worried About the Latest TikTok Wellness Fad. WSJ